Geraghty James A (CIK 0001239746)

Latest company ownership

Shares held
30,000
Last filed at
Jun 18, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
24,000
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
20,000
Last filed at
May 16, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 12, 2024 Dec 12, 2024 PALVELLA THERAPEUTICS, INC. Director Sell 27.5 -1 -100.00% ✗ $0
Aug 7, 2024 Oct 28, 2024 PALVELLA THERAPEUTICS, INC. Director Buy 90.0 +1 100.00% ✗ $1
Jun 28, 2021 Jun 29, 2021 Fulcrum Therapeutics, Inc. Director Buy 95.0 +10,000 12.39% ✗ $91.6K
Sep 10, 2018 Sep 12, 2018 Voyager Therapeutics, Inc. Director Buy 87.5 +3,000 4.08% ✗ $58.2K
Aug 17, 2018 Aug 21, 2018 Voyager Therapeutics, Inc. Director Buy 87.5 +3,000 4.25% ✗ $54.9K
May 15, 2018 May 16, 2018 PALVELLA THERAPEUTICS, INC. Director Buy 95.0 +10,000 100.00% ✗ $57.5K
Aug 17, 2017 Aug 17, 2017 PALVELLA THERAPEUTICS, INC. Director Buy 91.3 +10,000 100.00% ✗ $48.2K